This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent, primarily in Pharmaceutical Formulations. Top assignees: Warner-Lambert Company, Exxpharma Therapeutics LLC, American Leistritz Extruder Corp.. Active years: 1986-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Randolph, NJ (US) (1986)
- Stanhole, NJ (US) (1990)
- Stanhope, NJ (US) (1987 - 1994)
- Morris Plains, NJ (US) (1994 - 2022)
Company Filing History:


Years Active: 1986-2022
Areas of Expertise:
Title: The Innovative Mind of Isaac Ghebre-Sellassie
Introduction: Isaac Ghebre-Sellassie is a pioneering inventor known for his groundbreaking work in the field of pharmaceuticals and drug delivery systems. His relentless pursuit of innovation has led to numerous patents and advancements in the medical industry.
Latest Patents: Isaac Ghebre-Sellassie holds several recent patents related to novel drug formulations and delivery methods that have the potential to revolutionize the way medications are administered and absorbed in the body.
Career Highlights: With a background in pharmaceutical sciences and a keen interest in research and development, Isaac Ghebre-Sellassie has had a distinguished career working for leading pharmaceutical companies. His expertise in formulating new drugs and improving existing medications has earned him recognition as a thought leader in the industry.
Collaborations: Throughout his career, Isaac Ghebre-Sellassie has collaborated with top researchers, scientists, and medical professionals to bring his innovative ideas to life. His ability to work effectively in multidisciplinary teams has resulted in successful partnerships and groundbreaking discoveries.
Conclusion: Isaac Ghebre-Sellassie's passion for innovation and his dedication to improving healthcare through his inventions make him a standout figure in the world of pharmaceuticals. His contributions have the potential to positively impact the lives of countless individuals and shape the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile